Nestlé’s plan to partnering with Amazentis for development of mitochondrial health ingredient will enhance their business in medical nutrition industry which will promulgate the global medical nutrition market in future period.
Global: Nestlé Health Science announcement to enter into a global strategic partnership with Amazentis, a Swiss-based pioneer in science-driven nutritional health. Through this partnering, Nestlé will be global rights to use the patented Urolithin A technology of Amazentis in foods, beverages, dietary supplements, and medical nutritional products. Urolithin A as a metabolite that is naturally produced when consuming foods similar to pomegranate. Urolithin A is the first natural bioactive to boost function through clearing aging and damaged mitochondria from cells. This partnership supports Nestlé’s pursuit of growth opportunities both in consumer healthcare and medical nutrition. Urolithin A is a bioactive dietary metabolite that is naturally produced when eating certain foods, such as the pomegranate, though it is difficult for most people to get enough of this specialized nutrient from food alone.. Optimal mitochondrial function is central to cell metabolism and overall health. This is part of a new class of nutrients, called cellular nutrients, which go beyond traditional macro and micronutrients and are clinically proven to improve cellular health.
According to BlueWeave Consulting, Increasing number of people suffering from chronic conditions such as cancer and diabetes coupled with growing geriatric population base will drive the Medical Nutrition industry over the forecast timeframe. The Medical Nutrition deals with reduction of malnutrition, the balance diet, health care to be taken by the people in all ages of life. Medical Nutrition also refers as therapeutic compositions specially processed or formulated and intended for the dietary management of patients. This nutrition is strictly prescribed by medical professionals and is also consumed under medical supervision. Moreover, Medical Nutrition are providing vast benefits such as reduced risks for diseases, like heart disease, heart attack, and stroke, Protection from many types of cancers, reducing risks from heart disease, obesity, decreased bone loss and reduced risk for developing kidney stone and Increased energy.
High awareness levels of patients regarding certain foods and their positive impacts on health. Demand for medical nutrition therapy to increase the survival rate among infants is expected to boost the global medical nutrition industry in the coming years.
According to BlueWeave Consulting‘s upcoming report, Titled-“Global Medical Nutrition Market By Product Type (Standard Formula, Specialized Formula), By Indication (General Well-being, Renal Disorders, Hepatic Disorders, Oncology Nutrition), By End User(Adult, Geriatric, Pediatric), By Flavor(Regular, Flavored), By Region, Size and Forecast 2019- 2025”- Global Medical Nutrition market is expected with grow with a significant rate in forecast period, 2019-2025, due to increasing obese population due to unhealthy dietary habits as well as physical inactivity. Moreover, the rise in the medical nutrition market is boosted by the growing preference of patients for Home Parenteral & Enteral Nutrition (HPEN), and the reimbursements offered to the patients for medical nutrition. In addition, the demand for better quality therapy and healthcare facilities in developed countries will fuel the global nutrition market over forecast period.